Results 281 to 290 of about 67,931 (327)

Impact of Left Ventricular Assist Devices on the Quality of Life and Functional Outcomes in Advanced Heart Failure: A Comprehensive Review. [PDF]

Cureus
Maaz Shah S, Saleem H, Govindasamy V, Rathi A, Haris N, Ali R, Devi L, Omaruddin LE, Pavuluri KS, Joseph AM, Tariq A.   +10 more
europepmc   +1 more source

AI‐Assisted Decision‐Making for End‐Stage Organ Failure: Opportunities and Ethical Concerns

Artificial Organs, EarlyView.
Artificial intelligence (AI) can help physicians make better decisions for people with serious organ problems by analyzing medical data to predict outcomes. Patients want AI to support, not replace, personal care from doctors. Collaboration among experts ensures AI tools respect patient values and privacy.
John W. Haller, Olga D. Brazhnik, Kathleen N. Fenton   +2 more
wiley   +1 more source

The beneficial effect of early multimodal hospital rehabilitation on exercise tolerance and overall performance in patients with left ventricular assist devices. [PDF]

Arch Med Sci
Smolis-Bąk E, Załucka L, Kowalik I, Wolszakiewicz J, Dąbrowski R.   +4 more
europepmc   +1 more source

Follow‐Up of Left‐Ventricular Assist Device Patients With Telemonitoring: A National Retrospective Multicentric Study on the Satelia LVAD Web Application

Artificial Organs, EarlyView.
We evaluated the usefulness of remote monitoring for advanced heart failure patients using left‐ventricular assist devices (LVADs) in France. A national, retrospective study on a web application (Satelia) at nine locations was conducted. Specialized remote monitoring could facilitate LVAD follow‐ups and improve outcomes.
Clément Delmas, Anne‐Sophie Simoni, Céline Goeminne, Aude Boignard, Anne‐Céline Martin, Fabrice Vanhuyse, Erwan Flecher, Catherine Nafeh‐Bizet, Romain Itier, Nicolas Pages, Sophie Nisse‐Durgeat, Pascal Battistella, Karine Nubret‐le‐Coniat   +12 more
wiley   +1 more source

Sex-based Differences in the Utility and Outcomes of Left Ventricular Assist Devices. [PDF]

J Saudi Heart Assoc
Alasnag M, AlHabeeb W, Khaliel F.
europepmc   +1 more source

Hydraulic In Vitro Characterization of MR‐Conditional Blood Pumps

Artificial Organs, EarlyView.
Cardiac surgery in neonates requires close placement of cardiopulmonary bypass machines due to limited blood volume, complicating MR compatibility. This study introduces three MR‐conditional blood pump prototypes. None interfered with MRI imaging, though RF‐related sensor effects remain untested.
Dominik T. Schulte, Marcel Renggli, Henning Richter, Francesca Del Chicca, Michael Hofmann, Martin O. Schmiady, Marianne Schmid Daners   +6 more
wiley   +1 more source

Effectiveness of an intervention supporting shared decision making for destination therapy left ventricular assist device: The DECIDE-LVAD randomized clinical trial [PDF]

, 2018
et al,, LaRue, Shane J
core   +1 more source

Pump-Induced Hemolysis of Speed Modulated Axial-Flow Left Ventricular Assist Devices. [PDF]

Artif Organs
Borchers P, Österlein Kück A, Leonhardt S, Walter M.   +3 more
europepmc   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

Vitamin D Deficiency and Driveline Infections in Patients With Left Ventricular Assist Devices. [PDF]

Artif Organs
Borman WA, Landrigan LM, Berg NJ, Pickrell J, Guglin ME.   +4 more
europepmc   +1 more source